France
France-HiT
France-HiT
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Health systems in transition <strong>France</strong> 69<br />
Fig. 3.6<br />
Percentage of total expenditure on health by financing agent, 2013<br />
74% SHI<br />
5% General government<br />
7% OOP<br />
13% VHI<br />
0.6% Other<br />
Source: Eco-Santé, 2014.<br />
OOP payments are particularly important for optical care, dental care and<br />
drugs. They have remained relatively stable since 2000 as a result of an increase<br />
in public coverage and contrasting trends in VHI coverage. On one hand, VHI<br />
coverage increased with the implementation of free public complementary<br />
coverage for the less well off and with better coverage of medical devices (see<br />
section 3.5.1). On the other hand, it decreased with the de-listing of drugs with<br />
low SMR (see section 6.1.2) and the implementation of semi-gatekeeping and<br />
of deductibles (see section 3.3.1) (DREES, 2012).<br />
The respective contributions of financing agents vary across sectors and<br />
over time. Since the early 1990s, around 92% of hospital expenditure has been<br />
financed by SHI, but the share of outpatient care financed by SHI is smaller<br />
and has decreased over time, from 77% in 1980 to 63% in 2010 (Fenina, Garrec<br />
& Koubi, 2011). This can be explained, on the one hand, by the fact that in<br />
outpatient care some professionals are allowed to charge patients above the<br />
official SHI tariffs (extra-billing, see section 3.7.2) and, on the other hand, by<br />
the fact that since the late 1970s, most reforms have significantly increased<br />
patient user charges on medical goods and overall outpatient care.<br />
The financial flows in the French health care system are depicted in Fig. 3.7<br />
and described in detail in the following sections.